“Impact of Lebrikizumab on Patient-Reported Outcomes in Atopic Dermatitis: Prospective and Post Hoc Analyses of a Phase 2b Clinical Trial Demonstrate Clinically Meaningful Improvements”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 6, Oct. 2020, p. s94, https://doi.org/10.25251/skin.4.supp.94.